Show simple item record

dc.contributor.authorKlatte, Tobiasen
dc.contributor.authorStewart, Granten
dc.date.accessioned2019-03-08T00:30:31Z
dc.date.available2019-03-08T00:30:31Z
dc.date.issued2019-06en
dc.identifier.issn1759-4812
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/290319
dc.description.abstractIn patients with metastatic renal cell carcinoma, risk stratification according to the Memorial Sloan-Kettering Cancer Center or the International Metastatic Renal Cell Carcinoma Database Consortium classification systems is a crucial part of clinical assessment and essential for guiding management. New research has now demonstrated that disagreement in risk-group classification is common and prognostically relevant.
dc.format.mediumPrinten
dc.languageengen
dc.publisherNature Publishing Group
dc.rights
dc.rights.uri
dc.subjectHumansen
dc.subjectCarcinoma, Renal Cellen
dc.subjectKidney Neoplasmsen
dc.subjectRisk Assessmenten
dc.titleDisagreement in risk groups for metastatic renal cancer.en
dc.typeArticle
prism.endingPage333
prism.issueIdentifier6en
prism.publicationDate2019en
prism.publicationNameNature reviews. Urologyen
prism.startingPage332
prism.volume16en
dc.identifier.doi10.17863/CAM.37549
dcterms.dateAccepted2019-03-05en
rioxxterms.versionofrecord10.1038/s41585-019-0174-6en
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2019-06en
dc.contributor.orcidKlatte, Tobias [0000-0002-4392-6861]
dc.contributor.orcidStewart, Grant [0000-0003-3188-9140]
dc.identifier.eissn1759-4820
rioxxterms.typeJournal Article/Reviewen
cam.orpheus.successThu Jan 30 10:49:18 GMT 2020 - Embargo updated*
rioxxterms.freetoread.startdate2019-12-30


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record